To hear about similar clinical trials, please enter your email below

Trial Title: Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

NCT ID: NCT05854589

Condition: Melanoma (Skin)

Conditions: Official terms:
Melanoma

Study type: Interventional

Study phase: Phase 2

Overall status: Not yet recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: A pilot randomized controlled study, whereas a number of patients with clinically-diagnosed skin Melanoma (any location and any stage), and who were poorly responsive to at least one cycle of conventional and standard therapy, are equally divided into 2 groups, Active and Control groups. Each patient of the Active group will have their Melanoma covered by 2 drops of water, followed by applying Sodium Chloride granules to saturate the melanoma surface then add 2 more drops of water, then cover the NaCl-granules-covered Melanoma with a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any. Each patient of the Control group will undergo the same treatment as the Active group patients minus the Sodium Chloride granules.

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Drug
Intervention name: Sodium Chloride Granules
Description: Sodium Chloride crystals
Arm group label: Active Group - Sodium Chloride Crystal Topical

Intervention type: Other
Intervention name: Water
Description: Plain distilled water
Arm group label: Control Group - Plain Water topical application

Summary: This study evaluates the effectiveness of applying Hypertonic Saline solution directly on the Melanomas in reducing their sizes and/or number.

Detailed description: Many previous studies have shown that Cancer cells are over-hydrated, and that Hyponatraemia exists in many cases of Cancer. The Cancer cell's viability depends on Angiogenesis and formation of blood vessels that carry water and nutrients to the rapidly-dividing Cancer cells. This study tests the hypothesis that reducing the water content of Melanoma could lead to increasing its tonicity and hence inhibiting its growth. This reduction of water content can be achieved using Osmotic Pressure differential via applying highly saline solution - made by Sodium Chloride crystals wet with water - directly on the Melanoma for a certain amount of time, thus leading to water withdrawal from Melanoma cells. While the surrounding healthy skin cells can sustain temporary dehydration, Melanoma cells could be negatively affected.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patients with clinically-confirmed Melanoma (any location and any stage) who have poorly responded to at least one cycle of conventional and standard therapy (Chemotherapy, Radiation or Drug therapy). - Age 5 to 80 years old - Life expectancy of at least 1 year - Can understand and read English - Lives in USA. Patient who do not meet the Inclusion Criteria but still wish to participate will be accepted as Observational participants, but their Melanoma measurements will be not be taken into account when analyzing the Study statistically. Exclusion Criteria: - Skin eczema and/or other skin conditions contraindicated to skin dehydration. - Ulcers or open wounds close to Melanoma - Any medical condition that might cause the patient to lose consciousness - Participants who are not residents of USA.

Gender: All

Minimum age: 5 Years

Maximum age: 80 Years

Healthy volunteers: No

Start date: August 1, 2023

Completion date: June 30, 2024

Lead sponsor:
Agency: Rafik Batroussy
Agency class: Other

Source: Batroussy, Rafik

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05854589
https://www.nature.com/articles/nchem.2021
https://www.frontiersin.org/articles/10.3389/fimmu.2019.01141/full
http://royalsocietypublishing.org/doi/abs/10.1098/rspb.1932.0065
https://www.nature.com/articles/s41567-019-0680-8
https://www.genengnews.com/news/cell-stiffness-may-indicate-likelihood-of-cancer-metastasis/
https://www.longdom.org/open-access/the-dysfunction-of-metabolic-controlling-of-cell-hydration-precedes-warburg-phenomenon-in-carcinogenesis-jbb.10000e59.pdf

Login to your account

Did you forget your password?